AOL Money & Finance

Analyst calls: MO, SLB, BBY, AAPL, JPM, KR, ALU, GILD, BIDU, CEPH ...

More

Analyst upgrades:
  • JP Morgan upgraded Altria (NYSE: MO), citing the company's 25% cash return to shareholders by 2010 and its market leadership.
  • RBC Capital upgraded Core Laboratories (NYSE: CLB) based on its solid balance sheet and liquidity, strong market positions, and technology-driven products.
  • RBC Capital believes Schlumberger's (NYSE: SLB) earnings will decrease the least vs. its peers through 2010 and notes its breadth of products/services.
  • Tellabs (NASDAQ: TLAB) upgraded to Overweight from Equal Weight at Barclays.
  • Bally Tech (NYSE: BYI) upgraded to Buy from Neutral at Goldman.
  • Best Buy (NYSE: BBY) upgraded to Buy from Neutral at Piper Jaffray.
Analyst downgrades:
  • Goldman downgraded Apple (NASDAQ: AAPL) citing consumer spending concerns and valuation.
  • Merrill downgraded JP Morgan (NYSE: JPM) citing expectations for credit costs to get worse in the US.
  • Wachovia downgraded a handful of names, including Chesapeake (NYSE: CHK), in the Exploration & Production space as they believe natural gas prices have more downside in order to balance supply/demand fundamentals.
  • Alcatel-Lucent (NYSE: ALU) downgraded to Underperform from Hold at Jefferies.
  • Devon Energy (NYSE: DVN) downgraded to Hold from Buy at Deutsche Bank.
  • Kroger (NYSE: KR) downgraded to Neutral from Outperform at Credit Suisse.
Analyst initiations:
  • Gilead Sciences (NASDAQ: GILD) was initiated with a Buy at Merriman. Merriman expects the company's "significant" earnings growth to continue and has a target range of $53-$58.
  • Baidu.com (NASDAQ: BIDU) was initiated with a Sell and a target of $90 at Pali Capital. Pali believes Baidu's short to mid-term outlook is uncertain due to mass media and regulatory risks.
  • Ariba (NASDAQ: ARBA) was initiated with a Hold at KeyBanc. KeyBanc believes the current consensus expectations could be challenging to meet and finds the stock fairly valued.
  • Sepracor (NASDAQ: SEPR) was initiated with a Sell at Goldman.
  • King Pharma (NYSE: KG) was initiated with a Neutral at Goldman.
  • Cephalon (NASDAQ: CEPH) was initiated with a Buy at Goldman.

Reader Comments (Page 1 of 1)

Symbol Lookup
IndexesChangePrice
DJIA+17.4610,023.42
NASDAQ+7.122,112.44
S&P 500+2.671,069.30

Last updated: November 08, 2009: 11:55 PM

BloggingStocks Exclusives

Hot Stocks

DailyFinance Headlines

Latest from BloggingBuyouts

TheFlyOnTheWall.com Headlines

BioHealth Investor Headlines

WalletPop Headlines

My Portfolios

Track your stocks here!

Find out why more people track their portfolios on AOL Money & Finance then anywhere else.

BloggingStocks Partners

More from AOL Money & Finance

WalletPop Headlines